Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

NCT02376803 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02376803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2015
Completion date
April 27, 2018
Enrollment
217 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, deep venous thrombosis, dvt, thromboembolism, thrombus due to heart valve prosthesis